Safety Study of Aminolevulinic Acid (ALA) to Enhance Visualization and Resection of Tumors of the Brain
Clinical trial NCT01116661 · TERMINATED
Trial details
- NCT number
- NCT01116661
- Sponsor
- University of California, San Francisco
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-08-01
- Primary completion
- 2017-12-28
- Enrollment
- 199
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.